We’re proud to offer the Galleri® Multi-Cancer Early Detection Test—a powerful way to screen for cancer, now available through Everlywell.
This single blood test can detect a signal shared by 50+ types of cancer, many of which don’t have recommended screening tests. It works by looking for DNA shed by cancer cells—even before symptoms appear. If a cancer signal is detected, results also include a predicted Cancer Signal Origin to help your healthcare provider determine next steps.
†Your purchase may be HSA/FSA eligible. Check with your plan administrator. Everlywell is not responsible for contacting your plan administrator on your behalf. Everlywell works with a clinician network and CLIA-certified labs to provide lab tests. A licensed clinician will review your test request and order the test, if appropriate. If approved, the lab will process your sample, and lab results will be made available in Everlywell's online portal.
1 Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806
2 Liu MC, Oxnard GR, Klein EA, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020 Mar 30;31(6):745-59. doi: 10.1016/j.annonc.2021.05.806
3 Thierry AR, El Messaoudi S, Gahan PB, et al. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016 Jul 8;35:347–76. doi: 10.1016/j.annonc.2021.05.806
